← Back to All Filings

Cadre Holdings ($CDRE) Announces $175M Acquisition of TYR Tactical

High SignificanceOctober 29, 2025 at 9:02:13 AM EDT

Cadre Holdings, Inc.

$CDRE8-KCIK: 0001860543

Subscribe to track CDRE

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Cadre Holdings ($CDRE) Announces $175M Acquisition of TYR Tactical

Company: Cadre Holdings, Inc. (CDRE) Form: 8-K | Filed: 2025-10-29 Significance: High

Event: Corporate Acquisition Target: TYR Tactical

Transaction Details: • Type: Definitive Agreement to Acquire • Consideration: $175M ($150M cash, $25M in CDRE stock) • Value: $175,000,000

Key Insight: This is a highly significant strategic acquisition for Cadre, valued at nearly 10% of its market capitalization. The deal expands Cadre's footprint into European military markets and adds advanced manufacturing capabilities.

Market Context: The stock portion of the deal is expected to cause ~1.4% share dilution, a material event for shareholders. The acquisition is expected to be immediately accretive to earnings and adjusted EBITDA margins.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Cadre Holdings, Inc. (CDRE)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: Cadre Holdings has entered into a definitive agreement to acquire TYR Tactical for $175 million, a move representing approximately 9.94% of Cadre's market capitalization. This is a major strategic expansion.
  • Market Impact: The transaction is expected to be viewed positively due to its strategic rationale and accretive nature, though the stock component will introduce share dilution of over 1%.

Company Information

FieldValue
CompanyCadre Holdings, Inc.
Ticker SymbolCDRE
CIK0001860543
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

FieldValue
Namenull
CIKnull
Title/Positionnull
Relationshipnull

Transaction Details

FieldValue
Form Type8-K
Transaction Date2025-10-29
Transaction Codenull
Security TypeCash and Common Stock
Shares InvolvedNot specified, but $25M worth of stock
Price Per Sharenull
Total Value$175,000,000
Shares Owned Afternull
Ownership Typenull

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$175,000,000
% of Market Cap9.94%
Shares TransactedEst. ~577,634 (based on $25M stock at current valuation)
% of Shares OutstandingEst. ~1.42%
Post-Transaction OwnershipNot Applicable
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: For a company with a $1.76 billion market cap, a $175 million acquisition is a substantial investment and a clear signal of the company's growth strategy.
  • Ownership Concentration: This is a corporate action, not an insider trade, so it does not directly affect insider ownership concentration, aside from the shares issued to the sellers of TYR Tactical.
  • Dilution Impact: The issuance of $25 million in stock will dilute existing shareholders. Based on the current market cap and shares outstanding, this represents an estimated dilution of approximately 1.42%, which is a material figure that investors will watch closely.
  • Transaction Significance: The deal is highly significant, exceeding the 1% of market cap threshold by a wide margin. It signals a major strategic pivot or expansion.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Positive/Neutral
  • Reasoning: The market is likely to react positively to the strategic rationale, as the acquisition is expected to be immediately accretive to earnings and provides entry into new high-value markets. However, the share dilution may temper initial enthusiasm.

Volume & Sentiment

  • Expected Volume Impact: High. Major M&A announcements typically drive significant trading volume as investors digest the news and re-evaluate the company's prospects.
  • Sentiment Indicator: Bullish. The presentation highlights strong strategic benefits, including new technology, an expanded international footprint, and a resilient business model, which should foster a bullish long-term sentiment.

Investment Insights

Positive Market Indicators

  • The acquisition is expected to be immediately accretive to earnings and adjusted EBITDA margins.
  • Provides significant entry into new markets, particularly European military and defense.
  • Adds unique manufacturing capabilities for next-generation advanced materials.
  • TYR Tactical has a strong IP portfolio with over 80 patents.

Risk Factors

  • Integration risk: Failure to successfully integrate TYR Tactical's operations could negate the expected synergies.
  • Shareholder dilution from the $25 million stock component of the deal.
  • Execution risk in capitalizing on the new markets and customer relationships.

Key Takeaways

  1. Major Strategic Growth: Cadre is making a significant financial commitment (9.94% of its market cap) to acquire a key player in the personal protective equipment space.
  2. Expansion and Diversification: The deal diversifies Cadre's revenue stream, with TYR Tactical having a ~50% international revenue mix and a strong presence in European defense markets.
  3. Material Dilution: Shareholders will experience over 1.4% dilution from the new shares issued as part of the transaction consideration.

Additional Context

Transaction Notes

  • Financing: The deal is structured with $150 million in cash and $25 million in Cadre (CDRE) stock.
  • Strategic Rationale: According to the filing's exhibit, the acquisition meets all of Cadre's key M&A criteria, including strong brand recognition, attractive ROIC, and resiliency through market cycles.
Topics:#SECFiling#Form8K#CDRE#CadreHoldings#Acquisition#MergersAndAcquisitions#MandA#DefenseIndustry#HighSignificance#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.